• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 08P11-22
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/10/2023
Event Type  malfunction  
Event Description
The customer observed false reactive results for alinity i hbsag qualitative ii for one female patient.The patient was reactive on two tests 14 days apart.The patient was nonreactive with roche and siemens methods.The following data was provided: two screening alinity i hbsag results 14 days apart = 13 and 11 s/co.Samples were repeated and confirmed by neutralization per package insert.No specific data available for those tests.Per alinity i hbsag qualitative ii package insert < 1.00 nonreactive no retest required.= 1.00 reactive retest in duplicate no impact to patient management was reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false reactive results for alinity i hbsag qualitative ii for one female patient.The patient was reactive on two tests 14 days apart.The patient was nonreactive with roche and siemens methods.The following data was provided: two screening alinity i hbsag results 14 days apart = 13 and 11 s/co samples were repeated and confirmed by neutralization per package insert.No specific data available for those tests.Per alinity i hbsag qualitative ii package insert < 1.00 nonreactive no retest required.= 1.00 reactive retest in duplicate no impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false reactive alinity i hbsag qualitative ii confirmatory results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and return testing.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations for alinity i hbsag qualitative ii confirmatory reagent 08p11 and the complaint issue.Customer returns analysis was performed with patient specimens (ids (b)(6) ).The return specimens (ids (b)(6) ) generated repeat reactive results when tested with alinity i hbsag qualitative ii reagent, lot 44577fn00, but were not confirmed inhouse when tested with alinity i hbsag qualitative ii confirmatory reagent 08p11.Labeling was reviewed and found to be adequate.Based on our investigation, no systemic issue or deficiency with the alinity i hbsag qualitative ii confirmatory reagent 08p11 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG QUALITATIVE II CONFIRMATORY REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16777018
MDR Text Key313657929
Report Number3008344661-2023-00082
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08P11-22
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI04310; ALNTY I PROCESSING MODU, 03R65-01, AI04310
Patient SexFemale
-
-